Assessing Cost-Effectiveness in Obesity (ACE-Obesity): an overview of the ACE approach, economic methods and cost results

被引:90
|
作者
Carter, Rob [1 ]
Moodie, Marj [1 ]
Markwick, Alison [2 ]
Magnus, Anne [1 ]
Vos, Theo [3 ]
Swinburn, Boyd [4 ]
Haby, Michele M. [2 ]
机构
[1] Deakin Univ, Publ Hlth Res Evaluat & Policy Cluster, Burwood, Vic 3125, Australia
[2] Dept Human Serv, Publ Hlth Branch, Melbourne, Vic 3000, Australia
[3] Univ Queensland, Sch Populat Hlth, Ctr Burden Dis & Cost Effectiveness, Herston, Qld 4006, Australia
[4] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Melbourne, Vic 3125, Australia
关键词
MENTAL-HEALTH; INTERVENTIONS; CHILDREN;
D O I
10.1186/1471-2458-9-419
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The aim of the ACE-Obesity study was to determine the economic credentials of interventions which aim to prevent unhealthy weight gain in children and adolescents. We have reported elsewhere on the modelled effectiveness of 13 obesity prevention interventions in children. In this paper, we report on the cost results and associated methods together with the innovative approach to priority setting that underpins the ACE-Obesity study. Methods: The Assessing Cost Effectiveness ( ACE) approach combines technical rigour with 'due process' to facilitate evidence-based policy analysis. Technical rigour was achieved through use of standardised evaluation methods, a research team that assembles best available evidence and extensive uncertainty analysis. Cost estimates were based on pathway analysis, with resource usage estimated for the interventions and their 'current practice' comparator, as well as associated cost offsets. Due process was achieved through involvement of stakeholders, consensus decisions informed by briefing papers and 2(nd) stage filter analysis that captures broader factors that influence policy judgements in addition to cost-effectiveness results. The 2(nd) stage filters agreed by stakeholders were 'equity', 'strength of the evidence', 'feasibility of implementation', 'acceptability to stakeholders', 'sustainability' and 'potential for side-effects'. Results: The intervention costs varied considerably, both in absolute terms (from cost saving [6 interventions] to in excess of AUD50m per annum) and when expressed as a 'cost per child' estimate (from < AUD1.0 [reduction of TV advertising of high fat foods/high sugar drinks] to AUD31,553 [laparoscopic adjustable gastric banding for morbidly obese adolescents]). High costs per child reflected cost structure, target population and/or under-utilisation. Conclusion: The use of consistent methods enables valid comparison of potential intervention costs and cost-offsets for each of the interventions. ACE-Obesity informs policy-makers about cost-effectiveness, health impact, affordability and 2nd stage filters for important options for preventing unhealthy weight gain in children. In related articles cost-effectiveness results and second stage filter considerations for each intervention assessed will be presented and analysed.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Assessing Cost-Effectiveness in Obesity (ACE-Obesity): an overview of the ACE approach, economic methods and cost results
    Rob Carter
    Marj Moodie
    Alison Markwick
    Anne Magnus
    Theo Vos
    Boyd Swinburn
    Michele M Haby
    BMC Public Health, 9
  • [2] Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study
    Ananthapavan, Jaithri
    Sacks, Gary
    Brown, Vicki
    Moodie, Marj
    Nguyen, Phuong
    Veerman, Lennert
    Herrera, Ana Maria Mantilla
    Lal, Anita
    Peeters, Anna
    Carter, Rob
    PLOS ONE, 2020, 15 (06):
  • [3] COST-EFFECTIVENESS OF OBESITY INTERVENTIONS
    Veerman, Lennert
    Sacks, Gary
    Lee, Yong-Yi
    Cobiac, Linda
    Barendregt, Jan
    Vos, Theo
    Carter, Rob
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 20 - 20
  • [4] ACE inhibitors and ARBs: cost-effectiveness and safety
    Truter, I
    SA PHARMACEUTICAL JOURNAL, 2011, 78 (03) : 22 - 26
  • [5] A new approach to assessing the health benefit from obesity interventions in children and adolescents: the assessing cost-effectiveness in obesity project
    M M Haby
    T Vos
    R Carter
    M Moodie
    A Markwick
    A Magnus
    K-S Tay-Teo
    B Swinburn
    International Journal of Obesity, 2006, 30 : 1463 - 1475
  • [6] A new approach to assessing the health benefit from obesity interventions in children and adolescents: the assessing cost-effectiveness in obesity project
    Haby, M. M.
    Vos, T.
    Carter, R.
    Moodie, M.
    Markwick, A.
    Magnus, A.
    Tay-Teo, K-S
    Swinburn, B.
    INTERNATIONAL JOURNAL OF OBESITY, 2006, 30 (10) : 1463 - 1475
  • [7] Cost-Effectiveness of Pharmacotherapy to Reduce Obesity
    Veerman, J. Lennert
    Barendregt, Jan J.
    Forster, Megan
    Vos, Theo
    PLOS ONE, 2011, 6 (10):
  • [8] Cost-effectiveness of sibutramine in the treatment of obesity
    Warren, E
    Brennan, A
    Akehurst, R
    MEDICAL DECISION MAKING, 2004, 24 (01) : 9 - 19
  • [9] Obesity Cost-Effectiveness of bariatric Interventions
    Dickmann, Ines
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2014, 19 (04):
  • [10] Recent economic findings on childhood obesity: cost-of-illness and cost-effectiveness of interventions
    John, Juergen
    Wenig, Christina M.
    Wolfenstetter, Silke B.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (03): : 305 - 313